Exploring the role of drug-induced sleep endoscopy in optimizing upper airway stimulation therapy for non-responders
Sleep and Breathing · 2025
DOI: 10.1007/s11325-025-03468-z ↗Kurz gefasst
Fachartikel in der Zeitschrift Sleep and Breathing, 2025. Verfasst von E Kant und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology Head and Neck Surgery, Sint Antonius Hospital, Nieuwegein, the Netherlands. E.kant@umcutrecht.nl. Hauptthemen laut MEDLINE: Sleep Apnea, Obstructive, Hypoglossal Nerve, Electric Stimulation Therapy, Endoscopy. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Upper airway stimulation by means of unilateral hypoglossal nerve stimulation is an alternative therapy for patients with obstructive sleep apnea and continuous positive airway pressure intolerance or failure. Optimal device settings are essential for effective treatment of obstructive sleep apnea with this therapy. Some patients experience therapy failure, despite standard titration methods. We perform a drug induced sleep endoscopy with upper airway stimulation in these patients. This study provides an overview of this procedure and our patient outcomes.
Methods
Retrospective chart review of patients implanted with an upper airway stimulation device between 2015 and 2022.
Results
The drug-induced sleep endoscopy with upper airway stimulation therapy is performed in 29 non-responders of therapy. In seven patients, a change in device settings was sufficient to prevent an upper airway collapse during the drug-induced sleep endoscopy, while additional therapy was recommended for the remaining. Eventually, six patients were fitted with a change in device settings and fourteen patients were treated with additional therapy, being oral appliance therapy, barbed wire pharyngoplasty or alternative upper airway surgery. At follow-up, the apnea–hypopnea index declined significantly from 41.6 ± 15.0 to 23.2 ± 9.9 events/hour and resulted in eight additional responders to therapy.
Conclusion
The drug-induced sleep endoscopy might be a valuable addition in the clinical pathway of upper airway stimulation therapy. It provides a better evaluation of the stimulation process and offers the opportunity for alterations in settings or targeted additional therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otorhinolaryngology Head and Neck Surgery, Sint Antonius Hospital, Nieuwegein, the Netherlands. E.kant@umcutrecht.nl.
- Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands. E.kant@umcutrecht.nl.
- University Medical Center Utrecht Brain Center, University Medical Center Utrecht, Utrecht, the Netherlands. E.kant@umcutrecht.nl.
- Department of Pulmonology, Sint Antonius Hospital, Nieuwegein, the Netherlands.
- Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands.
- University Medical Center Utrecht Brain Center, University Medical Center Utrecht, Utrecht, the Netherlands.
ORCID-Profile: E Kant
Zitieren
APA
Kant, E., Hardeman, J. A., Stokroos, R. J., & Copper, M. P. (2025). Exploring the role of drug-induced sleep endoscopy in optimizing upper airway stimulation therapy for non-responders. Sleep and Breathing. https://doi.org/10.1007/s11325-025-03468-z
Vancouver
Kant E, Hardeman JA, Stokroos RJ, Copper MP. Exploring the role of drug-induced sleep endoscopy in optimizing upper airway stimulation therapy for non-responders. Sleep and Breathing. 2025. doi:10.1007/s11325-025-03468-z
BibTeX
@article{Kant2025,
author = {Kant, E and Hardeman, J A and Stokroos, R J and Copper, M P},
title = {Exploring the role of drug-induced sleep endoscopy in optimizing upper airway stimulation therapy for non-responders},
journal = {Sleep and Breathing},
year = {2025},
doi = {10.1007/s11325-025-03468-z}
}
EUVIMED